Innate immunity is the first line of defense in the body's immune system, providing rapid and nonspecific protection against a wide range of pathogens. It is an evolutionarily ancient form of immunity that acts immediately upon encountering foreign invaders. Key components of innate immunity include physical barriers like the skin and mucous membranes, as well as cellular components such as phagocytes (like neutrophils and macrophages) and natural killer (NK) cells. These cells are equipped to recognize and eliminate pathogens without the need for prior exposure. Innate immunity also involves the activation of the complement system, a group of proteins that enhance the immune response by promoting inflammation, phagocytosis, and the destruction of pathogens. While innate immunity provides rapid protection, it lacks the specificity and memory characteristic of adaptive immunity. Innate and adaptive immunity work collaboratively, with innate responses initiating the defense against pathogens, and adaptive responses developing over time for more precise and targeted protection. Dysregulation of innate immunity can lead to various diseases, including inflammatory conditions and autoimmune disorders. Understanding the complexities of innate immunity is crucial for developing strategies to modulate the immune system and combat infections and diseases effectively.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India